These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26388307)

  • 1. Racial differences in access to psoriasis biologics.
    Parraga SP; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2024 Dec; 35(1):2360572. PubMed ID: 38852941
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced doses of biological therapies in psoriasis: a new potentially "sustainable" frontier of psoriasis treatment.
    Ribero S; Ortoncelli M; Mastorino L; Quaglino P; Dapavo P
    Expert Opin Biol Ther; 2023; 23(9):867-868. PubMed ID: 37553946
    [No Abstract]   [Full Text] [Related]  

  • 3. Update on the natural history and systemic treatment of psoriasis.
    Richardson SK; Gelfand JM
    Adv Dermatol; 2008; 24():171-96. PubMed ID: 19256309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of biologic treatment in psoriasis patients with HIV: A systematic review.
    Sood S; Geng R; Heung M; Yeung J; Mufti A
    J Am Acad Dermatol; 2024 Jul; 91(1):107-108. PubMed ID: 38452816
    [No Abstract]   [Full Text] [Related]  

  • 5. No tuberculosis reactivations in psoriasis patients initiating new generation biologics despite untreated latent tuberculosis infection: Multicenter case series of 35 patients.
    Manzanares N; Vilarrasa E; López A; Alonso ML; Velasco M; Riera J; Del Alcázar E; Carrascosa JM; Azón A; Rivera R; Santos S; Salgado-Boquete L; Roncero M; Dorado M; Yelamos O; Delgado C; Gallardo F; Ferran M
    J Eur Acad Dermatol Venereol; 2024 Jan; 38(1):e26-e28. PubMed ID: 37561934
    [No Abstract]   [Full Text] [Related]  

  • 6. Blood monitoring during psoriasis treatment with biologics.
    Br J Dermatol; 2024 Mar; 190(4):e47. PubMed ID: 38488654
    [No Abstract]   [Full Text] [Related]  

  • 7. Bronchiectasis and non-tuberculous mycobacterial pulmonary infection.
    Koh WJ; Kwon OJ
    Thorax; 2006 May; 61(5):458; author reply 458. PubMed ID: 16648356
    [No Abstract]   [Full Text] [Related]  

  • 8. Comment on 'Immune response to COVID-19 mRNA vaccination in patients with psoriasis undergoing treatment with biologics'.
    Toplu SA; Altunisik N
    Clin Exp Dermatol; 2024 Mar; 49(4):394. PubMed ID: 37966357
    [No Abstract]   [Full Text] [Related]  

  • 9. Even well-controlled psoriasis patients have unmet treatment needs regardless of disease severity.
    Vaidya TS; Anderson KL; Feldman SR
    Dermatol Online J; 2015 Sep; 21(9):. PubMed ID: 26437293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-relevant needs and treatment goals in nail psoriasis.
    Blome C; Costanzo A; Dauden E; Ferrandiz C; Girolomoni G; Gniadecki R; Iversen L; Menter A; Michaelis-Wittern K; Morita A; Nakagawa H; Reich K; Augustin M
    Qual Life Res; 2016 May; 25(5):1179-88. PubMed ID: 26433952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric psoriasis: updates in biologic therapies.
    Sukhatme SV; Gottlieb AB
    Dermatol Ther; 2009; 22(1):34-9. PubMed ID: 19222515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long persistence of tumour necrosis factor-α antagonist-induced autoantibodies under subsequent treatment with ustekinumab but no adverse effects: a case study of 14 patients with psoriasis.
    Hoffmann JHO; Knoop C; Enk AH; Hadaschik EN
    Br J Dermatol; 2018 Jan; 178(1):e9-e10. PubMed ID: 28581119
    [No Abstract]   [Full Text] [Related]  

  • 13. The Use of Biologic Therapy in the Treatment of Acrodermatitis Continua of Hallopeau: A Review.
    Maliyar K; Crowley EL; Rodriguez-Bolanos F; O'Toole A; Gooderham MJ
    J Cutan Med Surg; 2019; 23(4):428-435. PubMed ID: 30938189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of biologics and other systemic agents in the treatment of pediatric psoriasis.
    Wright NA; Piggott CD; Eichenfield LF
    Semin Cutan Med Surg; 2010 Mar; 29(1):20-7. PubMed ID: 20430304
    [No Abstract]   [Full Text] [Related]  

  • 15. Non-tuberculous mycobacterial infections in psoriasis patients treated with biologics.
    Choi YM; Adelzadeh L; Wu JJ
    J Eur Acad Dermatol Venereol; 2016 Oct; 30(10):e99-e101. PubMed ID: 26388307
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of weight reduction on treatment outcomes in obese patients with psoriasis on biologic therapy: a randomized controlled prospective trial.
    Al-Mutairi N; Nour T
    Expert Opin Biol Ther; 2014 Jun; 14(6):749-56. PubMed ID: 24661040
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.